Strongly Inhibits Cat FIPV GS-441524 20mg/ML Purity

Basic Properties
Model Number: GS-441524
Trading Properties
Minimum Order Quantity: 10 vials
Price: Negotiable
Payment Terms: L/C,D/A,D/P,T/T,Western Union
Supply Ability: 100000 vials per month
Specifications
Function: Cat FIPV CAS: 1191237-69-0
Purity: 20mg/mL Test Method: HPLC UV
Storage: Cool Dry Place Shipping Method: Air(UPS, FedEx, TNT, EMS) Or Sea
MF: C12H13N5O4 Density: 1.74-1.94 G/cm3
Highlight: Fip Drugs For Cats, Cat FIPV GS-441524, Strongly Inhibits GS-441524
Product Description

Gallery

Strongly Inhibits Cat FIPV GS-441524 20mg/ML Purity

Strongly Inhibits Cat FIPV GS-441524 20mg/ML Purity 0

Strongly Inhibits Cat FIPV GS-441524 20mg/ML Purity 1


Strongly Inhibits Cat FIPV GS-441524 With Fast Delivery

Product Description

This medicine is an adenosine nucleotide analog antiviral, similar to remdesivi.This molecule was patented in 2009. In vitro studies of GS have determined it has a higher EC50 than remdesivi against a number of viruses, meaning GS is less potent.This medicine continues to be studied in the treatment of Feline Infectious Peritonitis Virus, that only infects cats.

Appearance Transparent liquid, powder or tablets
GS Standard 99.5%min
Size 5.5 ml/ Vial
Content 15mg/ml or 20mg/ml
Application For CAT FIP R&D Use ONLY
Wet FIP 6-7 mg/kg
Dry FIP 7-8 mg/kg
Ocular or Neuro FIP 8 mg/kg
Increased ocular/neuro 9 mg/kg
Max ocular/neuro 10 mg/kg

GS-441524 nucleoside is phosphorylated with the aid of using nucleoside kinases (likely adenosine kinase (ADK), that is the enzyme that phosphorylates the structurally comparable ribavirin), after which phosphorylated once more with the aid of using nucleoside-diphosphate kinase (NDK) to the energetic nucleotide triphosphate form. The triphosphate of GS-441524, GS-443902, is likewise the bioactive anti-viral agent generated with the aid of using remdesivir, however is generated with the aid of using a extraordinary biochemical mechanism from the later.

Intracellular triple-phosphorylation of GS-441524 yields its energetic 1'-cyano-substituted adenosine triphosphate analogue, which immediately disrupts viral RNA replication with the aid of using competing with endogenous NTPs for incorporation into nascent viral RNA transcripts and triggering not on time chain termination of RNA-structured RNA polymerase.